Abstract (EN):
The cytocompatibility of the degradation products of a Co-Cr orthopaedic alloy was investigated with particular focus on the dose-effect of an electrochemically dissolved alloy extract and of the corresponding separate metal ions on human osteogenic bone marrow derived cells. The extract solution contained 15 ppm of Co and 8 ppm of Cr as analysed by atomic absorption spectroscopy. Stock salt solutions of CoCl2 . 6H(2)O, CrCl3 . 6H(2)O and Na2CrO4 at corresponding concentrations were also prepared. Several dilutions of the above metallic solutions were tested for a period of 21 days on cells (third subculture) cultured in alpha-minimal essential medium containing foetal bovine serum and supplemented with antibiotics, dexamethasone ascorbic acid and beta-glycerophosphate. The osteoblast response to the presence of metal ions was evaluated by several biochemical parameters: cell viability (MTT reduction by intracellular enzymes), alkaline phosphatase activity (an osteoblast marker) and protein production (both intracellular and extracellular). Co-Cr corrosion products showed opposite effects to their respective metal salts only on day 1. With time the different metal solutions presented a similar pattern of inhibition. These results suggest that impaired bone formation in vitro can occur in the presence of Co-Cr corrosion products.
Language:
English
Type (Professor's evaluation):
Scientific
No. of pages:
6